Epizyme Inc (NASDAQ:EPZM)

Data as of 1:52pm ET
 -0.68 / -2.46%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Epizyme, Inc. operates as a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers. It is engaged in the creation of small molecule histone methyltransferase inhibitors (HMTi), a new class of personalized therapeutics for the treatment of patients with genetically defined cancers, based on breakthroughs in the field of epigenetics. Epizyme was founded by H. Robert Horvitz and Yi Zhang on November 1, 2007 and is headquartered in Cambridge, MA.

Contact Information

Epizyme, Inc.
400 Technology Square
Cambridge Massachusetts 02139
P:(617) 229-5872
Investor Relations:



Individual stakeholders57.57%
Mutual fund holders26.21%
Other institutional14.89%

Top Executives

Robert J. GouldChief Executive Officer & Director
Jason P. RhodesPresident, Chief Financial Officer & Treasurer
Robert A. CopelandChief Scientific Officer & Executive VP
Eric E. HedrickChief Medical Officer
Manisha PaiSenior Director-Corporate Communications

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.